Meta-analysis of statin and outcomes of coronavirus disease 2019 (COVID-19): Reconsideration is needed
- PMID: 34366177
- PMCID: PMC8255189
- DOI: 10.1016/j.numecd.2021.06.009
Meta-analysis of statin and outcomes of coronavirus disease 2019 (COVID-19): Reconsideration is needed
Conflict of interest statement
Declaration of competing interest Neither of the authors declared a conflict of interest.
Comment in
-
Authors' response: Meta-analysis of statin and outcomes of coronavirus disease 2019 (COVID-19).Nutr Metab Cardiovasc Dis. 2021 Aug 26;31(9):2740-2742. doi: 10.1016/j.numecd.2021.06.008. Epub 2021 Jun 29. Nutr Metab Cardiovasc Dis. 2021. PMID: 34362637 Free PMC article. No abstract available.
Comment on
-
Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection.Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1613-1615. doi: 10.1016/j.dsx.2020.08.023. Epub 2020 Aug 26. Diabetes Metab Syndr. 2020. PMID: 32882643 Free PMC article.
-
Statin and outcomes of coronavirus disease 2019 (COVID-19): A systematic review, meta-analysis, and meta-regression.Nutr Metab Cardiovasc Dis. 2021 Jun 7;31(6):1662-1670. doi: 10.1016/j.numecd.2021.02.020. Epub 2021 Feb 27. Nutr Metab Cardiovasc Dis. 2021. PMID: 33838992 Free PMC article.
References
-
- Shamseer L., Moher D., Clarke M., Ghersi D., Liberati A., Petticrew M. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. Bmj. 2015:349. - PubMed
-
- Ding D., Nguyen B., Gebel K., Bauman A., Bero L. Duplicate and salami publication: a prevalence study of journal policies. Int J Epidemiol. 2020;49(1):281–288. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
